Clinical trial / 2014
Oral yeast-derived beta-(1,3) glucan increased salivary lysozyme, CRP, and calprotectin in children with chronic respiratory problems.
Researchers evaluated the effects of 30-day oral administration of 100 mg/day of glucan in 60 children aged 8-12 years with chronic respiratory problems. Salivary levels of albumin, lysozyme, CRP, and calprotectin were measured. The treatment resulted in a significant increase in the production of lysozyme, CRP, and calprotectin.
- Study type
- Clinical trial
- Who was studied
- 60 children ages 8-12 years with chronic respiratory problems
- What was measured
- Salivary levels of albumin, lysozyme, C-reactive protein (CRP), and calprotectin
THE PAPER
Clinical trials of yeast-derived β-(1,3) glucan in children: effects on innate immunity.
Richter J, Svozil V, Král V, Rajnohová Dobiášová L, Stiborová I, Vetvicka V. Ann Transl Med, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.